Business Context and Reporting Period
Company: Mustang Bio, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 6, 2022
Reporting Period: Specific event date (July 6, 2022)
This filing reports the formal execution of a corporate governance action previously approved by stockholders. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
This Form 8-K does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing is strictly administrative regarding corporate charter amendments.
Material Changes
- Authorized Share Increase: The Company filed a certificate of amendment with the Delaware Secretary of State on July 6, 2022, to increase the number of authorized Common Stock shares by 50,000,000.
- New Total Authorized Shares: The total number of authorized shares of Common Stock is now 200,000,000.
- Stockholder Approval: This amendment was approved by stockholders at the 2022 Annual Meeting of Stockholders, as previously disclosed in a Form 8-K filed on June 24, 2022.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document serves solely to disclose the filing of the Certificate of Amendment (Exhibit 3.1).
Investor Verification Checklist
- Verify the total authorized share count is now 200,000,000 shares.
- Confirm the filing date of the Certificate of Amendment with the Delaware Secretary of State (July 6, 2022).
- Review the June 24, 2022 Form 8-K for details on the stockholder vote that authorized this change.
- Check Exhibit 3.1 of this filing for the full text of the Certificate of Amendment.